Athira Pharma, Inc. (ATHA) Misses Q3 EPS by 155c

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q3 EPS of ($1.68), $1.55 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Meta plans to build prediction markets app called Arena - NYT
• Craig-Hallum Upgrades Backblaze Inc (BLZE) to Buy